FDA panel endorses Johnson & Johnson COVID-19 vaccine
It might not be paradise waiting, but the U.S. is likely to get a third COVID-19 vaccine in the coming days. A Food and Drug Administration (FDA) advisory panel on Friday endorsed Johnson & Johnson’s coronavirus vaccine and recommended the agency grant emergency authorization, moving the nation’s third vaccine one step closer to getting into Americans’ arms.
The panel voted 22-0 that the benefits outweigh the risks for adults age 18 and older.
FDA could give the green light to the single-dose vaccine as early as Saturday.
Vaccinations will begin once a Centers for Disease Control and Prevention (CDC) panel recommends the vaccine and the CDC accepts that recommendation. The CDC panel is scheduled to meet Sunday.